Introduction
============

Epilepsy is a chronic paroxysmal disease frequently encountered in neurology practice and necessitates adaptation to the disease and its side effects. The indicator of the disease progression is the frequency and severity of seizures. Genetic, environmental, and living conditions, together with emotional status, influence the disease severity and attack frequency. The thought of having a chronic disease, difficulties experienced during treatment, and physical and psychosocial problems disturb the emotional status.

Illness perception is the reflection of individuals' beliefs and expectations related to a disease or manifestations.[@b1-ndt-13-551] This concept is based on Leventhal's self-regulatory model.[@b2-ndt-13-551] According to this model, individuals create schemes related to diseases and other life-threatening conditions in their minds within the frame of information they were presented from concrete and abstract sources. These cognitive models, created by the patients, also involve beliefs related to treatment and attitude control.

This cognitive model, consisting of beliefs, interpretations, and emotional and behavioral responses manifested differently in each individual, is the factor that determines the individual's understanding of the disease, the style of coping with the disease, the development of psychiatric disorder, and the quality of life.

Illness Perception Questionnaire (IPQ) was first developed by Weinman et al[@b3-ndt-13-551] in 1996 and has been revised by Moss-Morris et al[@b4-ndt-13-551] in 2002 (IPQ-R). The development of Turkish version of the scale, together with its validity--reliability study, was performed by Kocaman et al[@b5-ndt-13-551] in 2007. In another study conducted in 2007, the validity--reliability of the scale was evaluated in Turkish cancer patients.[@b6-ndt-13-551]

The aims of this study were primarily to evaluate the IPQ in Turkish epilepsy patients, a new patient group, and secondarily to investigate evidence of an effect of earthquake as a serious life event on illness perceptions. Beck Depression Scale (BDS) was used to assess depression.

Materials and methods
=====================

Selection of cases
------------------

On 23 October 2011, a destructive earthquake of 7.2 magnitude, the epicenter of which was Van Erciş, occurred in the eastern part of Turkey. The earthquake caused significant mortality and morbidity with a large number of homeless and jobless people. According to the official records, 644 people died and 252 people survived from the wreckage.[@b7-ndt-13-551] This earthquake brought many economic, social, and emotional problems in its wake.

Patients who were admitted consecutively to Van Erciş State Hospital Neurology Outpatient Clinic between February and May 2012 and diagnosed with epilepsy were included in the study as the group that had experienced the earthquake (Group 1). Patients who were living in the province of Mardin, admitted consecutively to the Mardin State Hospital Neurology Outpatient Clinic between May and December 2012, and diagnosed with epilepsy were included in the study as the group that had no earthquake experience (Group 2). This study was approved by the Ankara Training and Research Hospital Institutional Review Board. The participants were selected among volunteers; their written informed consents were obtained. The diagnosis of epilepsy was made by a neurologist, according to the International League Against Epilepsy (ILAE).[@b8-ndt-13-551]

Patients who had the diagnosis of epilepsy for at least 1 year, were older than 16 years, who knew the Turkish language, and were educated for at least 5 years were included in the study. Patients who were not present in Erciş during the earthquake, who had an additional psychiatric or chronic disorder, and who encountered seizure in the last week prior to the study were not included in the study.

The study was conducted with the participation of 48 epilepsy patients (15 females \[31.3%\] and 33 males \[68.8%\]), with the mean age of 29.5 years ([Table 1](#t1-ndt-13-551){ref-type="table"}). The number of epilepsy patients with earthquake experience (Group 1) was 21, and the number of epilepsy patients having no earthquake experience (Group 2) was 27 ([Table 1](#t1-ndt-13-551){ref-type="table"}).

In all selected patients, by detailed clinical examination, the presence of any associated disorder was excluded. The demographic data, seizure frequency, and duration of the disease were recorded on standard study forms. It was determined that 56.3% of the participants were married, 31.3% were educated for at least 5 years, and 25% were unemployed ([Table 1](#t1-ndt-13-551){ref-type="table"}). In epilepsy patients with earthquake experience, the duration of the disease median (range) values were 7 (5--15) years, and seizure frequency median (range) values were 0 (0--5) seizure per year. In epilepsy patients having no earthquake experience, the duration of epilepsy median (range) were 8 (5--15) years and the seizure frequency median (range) values were as 1 (0--12) seizure per year ([Table 1](#t1-ndt-13-551){ref-type="table"}).

Collection of data and measurements
-----------------------------------

The interview form, IPQ, and BDS were applied to the participants.

### Interview form

The demographic data, seizure frequency, and the drugs that the participants had been using were similar.

### Illness Perception Questionnaire

The scale consists of three dimensions, being illness identity, attributions concerning the disease, and probable causes. The dimension of illness identity questions 14 frequently met disease manifestations, such as pain, nausea, and weight loss. For each one of these, the individual is first asked, "whether it was encountered since the beginning of the disease" and then "whether this manifestation is related to the disease". This subscale is organized in such a format that both questions can be replied as yes/no. The sum of "yes"-rated replies to the second question forms the evaluation result in terms of illness identity subscale. The dimension of attributions concerning the disease consists of 38 items, and it is a five-level Likert-type scale (ranging from "I strongly agree" to "I strongly disagree"). This dimension involves seven subscales. These are named timeline (acute/chronic), consequences, personal control, treatment control, illness coherence, timeline (cyclical), and emotional representations. The timeline subscale investigates the perceptions of the individual related to the duration of the disease and is grouped as acute, chronic, and cyclical. The consequences subscale investigates the beliefs of the individual about the disease severity and its probable effects on the individual's physical, social, and psychological functionality. Personal control investigates the individual's internal control perception about the duration, progression, and treatment of the disease. Treatment control investigates the beliefs of the patient about the effectiveness of administered treatment. Illness coherence investigates to what extent the individual understands or apprehends the illness. The subscale of emotional representations investigates the individual's feelings related to the disease. The dimension of illness causes consists of 18 items involving probable causes related to the formation of illnesses. Five-level, Likert-type measurement is used. This dimension investigates the thoughts of the individual about the probable causes of his or her illness and involves four subscales. They are psychological attributions, risk factors, immunity, and accident/chance. For qualitative evaluation, the individual is also required to write down three factors that are considered as the most important causes of the illness, at the end of the scale.

### BDS

BDS developed by Beck et al,[@b9-ndt-13-551] Turkish validity and reliability of which was performed by Hisli,[@b10-ndt-13-551] was applied.

Statistical analyses
--------------------

Analyses were conducted by the SPSS package program (version 11.5; SPSS Inc., Chicago, IL, USA). Data were analyzed using frequency distributions for categorical variables and descriptive statistics for the continuous variables, and the results were given as "mean ± SD".

The reliability of IPQ-R's subscales was investigated by calculating Cronbach's α scores. If the subscales were reliable, the analysis was started. Kolmogorov--Smirnov normality test was used for continuous variables. According to the test results, independent sample *t*-test was chosen for normally distributed variables (*P*\>0.05) and Mann--Whitney *U* test was chosen for non-normally distributed variables (*P*\<0.05) for statistical analysis. Intercorrelations between the subscales of IPQ-R were examined using Spearman's correlation test.

Results
=======

No statistically significant differences were found between the two groups in terms of age, seizure frequency, and duration of illness (*P*\>0.05; [Table 1](#t1-ndt-13-551){ref-type="table"}).

In questioning regarding the dimension of the illness type, the most commonly encountered symptoms were found as fatigue (76.6%) and headache (72.9%) in epilepsy patients ([Table 2](#t2-ndt-13-551){ref-type="table"}).

As the result of reliability analysis, performed for dimension about attributions concerning the disease, this dimension was found as consisting of seven factors, the reliability coefficient ranging between 0.779 and 0.874. Regarding the probable causes, the reliability coefficient, consisting of three factors, was determined to range between 0.715 and 0.774 ([Table 3](#t3-ndt-13-551){ref-type="table"}).

In the dimension of attributions concerning illness, no significant differences were found between the groups in terms of personal control, timeline (acute/chronic), emotional representations, illness coherence, consequences, treatment control, and timeline (cyclical) subscales ([Table 4](#t4-ndt-13-551){ref-type="table"}).

In the dimension of probable causes, no significant differences were found between the two groups in terms of psychological attributes, risk factors, and immunity subscales ([Table 4](#t4-ndt-13-551){ref-type="table"}).

Regarding the BDS score, the levels of Group 1 and Group 2 were 16, and no significant difference was found between the groups (*z*=−0.895, *P*\>0.05).

When the relationships between the subscales of IPQ were analyzed, it was determined that, as illness coherence increased or negative perception related to illness consequences decreased, the negative beliefs of individuals related to the duration of illness decreased. It was determined that as positive thoughts regarding treatment control increased, the positive control thoughts of individuals regarding their illnesses also increased. Positive relationships were determined between timeline (cyclical) and emotional representations and between timeline (cyclical) and consequences. There was a negative relationship between psychological attributions and illness coherence.

Discussion
==========

The results of our study indicated that IPQ-R could be used as a valid and reliable measurement tool for the evaluation of illness perception in the patient group having the diagnosis of epilepsy. The internal reliabilities of all subscales were high. Cronbach's α values ranged between 0.715 and 0.814. The determination of almost the same mean values of subscales in the group with earthquake experience and the group with no earthquake experience supported the accuracy of the study in terms of both validity and reliability. Although the difficulties related to cultural differences were envisioned prior to the study, it was also observed to be quite suitable for Turkish culture. As the IPQ has not been tested in epilepsy patients in Turkey, this article has potential to contribute to the evidence base.

IPQ has been adapted to many countries and has been in use for many chronic disorders.[@b11-ndt-13-551]--[@b16-ndt-13-551] In the literature, it has been found that IPQ was used in epilepsy patients in a limited number of studies.[@b17-ndt-13-551] To the best of our knowledge, in our country, this was the first study in which IPQ-R was used in epilepsy patients. The results of this study demonstrated that IPQ-R could be used reliably in the Turkish epilepsy patients.

Owing to the high number of patients and the high morbidity both in Turkey and in the world, together with its socioeconomic burden, epilepsy is a chronic disorder, which has been broadly discussed and tried to be solved in recent years. Failure to reach the treatment goals despite significant improvements in diagnostic, therapeutic, and follow-up methods has led to the investigation of different factors in patients. In patients with the diagnosis of epilepsy, the evaluation of illness perception data and the reflection of these data to the education and treatment plans of the patients may provide additional benefit in achieving seizure control.

The illness perception has been found to determine the quality of life, the compliance with treatment, and the psychosocial response in many diseases.[@b18-ndt-13-551]--[@b24-ndt-13-551] The studies conducted to determine the relationship of illness perception and the outcome of the diseases other than epilepsy have revealed that the course of the disease was better in individuals having a high perception of internal control.[@b25-ndt-13-551],[@b26-ndt-13-551] In our study, when the relationships between subscales of IPQ-R were investigated, it was found that in individuals who were able to understand their disorders and who developed positive thoughts about the consequences of the illness, the negative beliefs in terms of disease duration decreased. In addition, it was found that as positive thoughts regarding treatment control increased, the positive control thoughts of the individuals regarding their illnesses also increased. This result was in correlation with the results of the original study conducted by Moss-Morris et al[@b4-ndt-13-551] in 2002. According to this result, the illness perception should be taken into consideration in order to improve the compliance with treatment in epilepsy patients.

Earthquake, which is an acute severe life event, did not change illness perception in our cohort. This interesting data might be caused by the personal characteristics of perception. The illness perception consists of mental representations of the disease and may be not related to acute life events or stressors. However, our study population was very small. Therefore, this result may not be generalized to all population. The relationship between other severe life events and illness perception in epilepsy patients should be targeted in future studies with larger samples.

It must be emphasized that patients' other severe life events, such as recent bereavement, were not investigated for the cohort for Group 1 and Group 2. This is a limitation for this work. Another limitation is the small sample size. Although it is clear that it is difficult to find many patients with epilepsy having suffered an earthquake experience, the total number of patients is rather scanty.

Conclusion
==========

Illness perception is the cognitive perspective of the illness status. Patients try to explain their illnesses in the light of their personal experiences, knowledge, values, beliefs, and demands.[@b27-ndt-13-551] Recognition of situations, in which illness perception creates problems, by the physician and taking necessary measure may increase the success rate of treatment.

The abstract of this article was presented in Turkish at the 51st National Congress of the Turkish Neurological Society, Antalya, Turkey, from 21 to 27 November 2015.
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###### 

Demographic and clinical characteristics of the study population

  Characteristics                                 Whole sample (n=48)   Group 1 (n=21)[a](#tfn1-ndt-13-551){ref-type="table-fn"}   Group 2 (n=27)[b](#tfn2-ndt-13-551){ref-type="table-fn"}   *P*-value[c](#tfn3-ndt-13-551){ref-type="table-fn"}
  ----------------------------------------------- --------------------- ---------------------------------------------------------- ---------------------------------------------------------- -----------------------------------------------------
  Age (in years), mean or median (IR)             29.5 (24--33.8)       31 (22--33.5)                                              27 (25--35)                                                0.692
  Gender (female/male)                            15/33                 6/15                                                       9/18                                                       0.487
  Marital status (n)                                                                                                                                                                          0.446
   Single                                         21                    10                                                         11                                                         
   Married                                        27                    11                                                         16                                                         
  Years of education                                                                                                                                                                          0.991
   5                                              15                    6                                                          9                                                          
   5--8                                           8                     4                                                          4                                                          
   8--12                                          15                    6                                                          9                                                          
   \>12                                           10                    5                                                          5                                                          
  Job                                                                                                                                                                                         0.199
   Housewife, n (%)                               4 (8.3)               1                                                          3                                                          
   Officer, n (%)                                 8 (16.7)              5                                                          3                                                          
   Laborer, n (%)                                 16 (33.4)             8                                                          8                                                          
   Student, n (%)                                 8 (16.7)              4                                                          4                                                          
   Unemployed, n (%)                              12 (25.0)             4                                                          8                                                          
  Seizure frequency (seizure/year), median (IR)   0 (0--6)              0 (0--5)                                                   1 (0--12)                                                  0.411
  Duration of epilepsy (years), median (IR)       7.5 (5--15)           7 (5--15)                                                  8 (5--15)                                                  0.264

**Notes:**

Group 1 consisted of participants who were living in Erciş and experienced earthquake.

Group 2 consisted of participants who were living in Mardin and did not experience earthquake.

Independent sample *t*-test for normally distributed variables and Mann--Whitney *U* test for non-normally distributed variables were performed; statistical tests were performed between Group 1 and Group 2.

**Abbreviation:** IR, interquartile range.

###### 

The distribution of disease manifestations and their association with the disease

  Manifestations                  Encountered this manifestation since the beginning of my disease   This manifestation is related to my disease        
  ------------------------------- ------------------------------------------------------------------ --------------------------------------------- ---- ------
  Fatigue                         36                                                                 76.6                                          27   56.3
  Headache                        35                                                                 72.9                                          31   64.6
  Pain                            29                                                                 60.4                                          21   43.8
  Dizziness                       28                                                                 58.3                                          22   45.8
  Loss of strength                27                                                                 56.3                                          21   43.8
  Sleep disorders                 25                                                                 53.2                                          19   39.6
  Burning sensation in the eyes   20                                                                 41.7                                          11   22.9
  Stomach complaints              17                                                                 35.4                                          10   20.8
  Nausea                          17                                                                 35.4                                          9    18.8
  Joint stiffness                 16                                                                 33.3                                          11   22.9
  Difficulty in breathing         15                                                                 31.3                                          8    16.7
  Weight loss                     13                                                                 27.1                                          7    14.6
  Snuffling                       12                                                                 25.0                                          8    16.7
  Sore throat                     11                                                                 22.9                                          2    4.2

###### 

The results of the reliability analysis of illness perception scale subscales

  Subscale                              Number of items   n    Cronbach's *α*   Level of reliability
  ------------------------------------- ----------------- ---- ---------------- ----------------------
  Attributions concerning the disease                                           
   Personal control                     6                 48   0.785            Quite reliable
   Timeline (acute/chronic)             6                 48   0.779            Quite reliable
   Emotional representations            6                 48   0.783            Quite reliable
   Illness coherence                    5                 48   0.781            Highly reliable
   Consequences                         6                 48   0.782            Quite reliable
   Treatment control                    5                 48   0.782            Quite reliable
   Timeline (cyclical)                  4                 48   0.874            Quite reliable
  Probable causes                                                               
   Psychological causal attributions    6                 48   0.743            Quite reliable
   Risk factors                         7                 48   0.715            Quite reliable
   Immunity                             3                 48   0.774            Quite reliable

###### 

The analysis of whether there is a difference in earthquake experience between groups in terms of illness perception and BDS subscales

  Subscale                              Group       Mean                    SD      *T*       *P*-value
  ------------------------------------- ----------- ----------------------- ------- --------- ---------------
  Attributions concerning the disease                                                         
   Personal control                     Group 1     3.31                    0.647   −0.506    0.615
                                        Group 2     3.40                    0.662             
   Timeline (acute/chronic)             Group 1     3.33                    0.578   0.713     0.480
                                        Group 2     3.19                    0.751             
   Emotional representations            Group 1     3.16                    1.019   −1.007    0.319
                                        Group 2     3.42                    0.680             
   Illness coherence                    Group 1     2.99                    1.055   1.168     0.249
                                        Group 2     2.64                    1.029             
   Consequences                         Group 1     3.16                    0.838   −0.276    0.784
                                        Group 2     3.22                    0.672             
   Treatment control                    Group 1     3.68                    0.793   −1.342    0.186
                                        Group 2     3.98                    0.732             
   Timeline (cyclical)                  Group 1     3.12                    0.842   −0.733    0.467
                                        Group 2     3.31                    0.942             
  Probable causes                                                                             
   Psychological causal attributions    Group 1     3.01                    0.708   0.951     0.347
                                        Group 2     2.79                    0.899             
   Risk factors                         Group 1     1.94                    0.692   0.568     0.573
                                        Group 2     2.05                    0.666             
   Immunity                             Group 1     2.37                    0.802   1.467     0.149
                                        Group 2     2.03                    0.781             
                                                                                              
  **Beck depression scale**             **Group**   **Median (Min--Max)**           ***Z***   ***P*-value**
                                                                                              
  BDS score                             Group 1     16 (0--42)                      0.895     0.371
                                        Group 2     16 (0--34)                                

**Abbreviations:** BDS, Beck Depression Scale; Min, minimum; Max, maximum.
